251 Efficacy and safety of iparomlimab and tuvonralimab in previously treated patients with recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase 2 clinical trial (DUBHE-C-206)Hanmei Lou, Jihong Liu, Dapeng Li et al.|International Journal of Gynecological Cancer|2024Cited by 5